U.S. markets closed

Dundee Corporation (DNDEF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
15.620.00 (0.00%)
At close: 11:25AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close15.62
BidN/A x N/A
AskN/A x N/A
Day's Range15.62 - 15.62
52 Week Range14.50 - 15.63
Avg. Volume0
Market Cap954.233M
Beta (5Y Monthly)1.55
PE Ratio (TTM)N/A
EPS (TTM)-0.40
Earnings DateN/A
Forward Dividend & Yield1.03 (6.56%)
Ex-Dividend DateJun 15, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for DNDEF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      Dundee Corporation Provides Target Release Date for Second Quarter 2022 Financial Results and Conference Call

      TORONTO, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A, DC.PR.B, DC.PR.D) (“Dundee” or the “Company”) announced today that its second quarter 2022 financial results will be released after market close on August 10, 2022, followed by a conference call with management for investors and analysts on August 11, 2022 at 10:00 am ET. Analysts and investors are invited to participate using the following dial-in numbers or webcast link: Participant Number (CAN Toll-free): 1-855-669-9657

    • GlobeNewswire

      Dundee Corporation Announces Voting Results From 2022 Annual Meeting Of Shareholders

      TORONTO, June 24, 2022 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (“Dundee” or the “Company”) is pleased to announce the voting results from its Annual Meeting of Shareholders (the “Meeting”) which was held via live audio webcast on Thursday, June 23, 2022. Shareholders voted in favour of all items of business before the Meeting, as follows: Appointment of Auditor PricewaterhouseCoopers LLP, Chartered Accountants were appointed as Auditor of the Company and the directors of the Company w

    • GlobeNewswire

      Dundee Corporation Portfolio Holding, TauRx Pharmaceuticals Ltd., Announces Move Toward Regulatory Submission Following Initial Data From LUCIDITY Trial

      TORONTO, May 31, 2022 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (the “Corporation” or “Dundee”) today announces that TauRx Pharmaceuticals Ltd. (“TauRx”), a leader in tau-based research in Alzheimer’s, unveiled initial data from the randomised portion of their widely followed Phase 3 clinical trial, LUCIDITY (NCT03446001). Dundee holds 1,015,008 shares in TauRx. For a copy of TauRx’s official announcement, please visit: